When Microdosing May Not Be Appropriate Microdosing is not appropriate when core safety or metabolic foundations have not been addressed
Low blood sugar levels may occur, especially when combined with other diabetes medications
& Melgert, B
However, its essential to approach its preparation with care
Notably, fibroblast growth factor 2 (FGF2), leukemia inhibitory factor (LIF), and insulin-like growth factor 1 (IGF1), collectively termed FLI medium, significantly improve mouse oocyte quality, as evidenced by enhanced blastocyst formation rates
This is harmful as it can lead to serious problems, such as dehydration and salt (electrolyte) disturbances, and in some cases dependence